Philosophy Capital Management’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-858,670
Closed -$2.1M 33
2022
Q2
$2.1M Buy
858,670
+133,670
+18% +$636K 0.27% 32
2022
Q1
$5.02M Buy
725,000
+415,958
+135% +$4.41M 0.42% 28
2021
Q4
$4.91M Buy
+309,042
New +$6.19M 0.96% 25

Other funds holding RNLX

Philosophy Capital Management's RNLX Position: Q3 2022 in Review

Philosophy Capital Management sold out of Renalytix plc American Depositary Shares (RNLX) in Q3 2022, closing a stake of 858,670 shares — an estimated $2.1M sold.

Philosophy Capital Management first reported a position in RNLX in Q4 2021 and held it in 3 quarters. The position peaked at $5.02M in Q1 2022. 27 funds tracked by Wall St. Rank hold RNLX as of Q3 2022.

  • Philosophy Capital Management reported no remaining Renalytix plc American Depositary Shares position as of Q3 2022 after selling out during the quarter.
  • Philosophy Capital Management sold 858,670 Renalytix plc American Depositary Shares shares in Q3 2022, an estimated $2.1M.
  • Philosophy Capital Management first reported a position in Renalytix plc American Depositary Shares in Q4 2021 and held it in 3 quarters.
  • Philosophy Capital Management's Renalytix plc American Depositary Shares position peaked at $5.02M in Q1 2022.
  • 27 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q3 2022.

Based on Philosophy Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.